2021
DOI: 10.1016/j.ymgme.2021.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers for liver disease in urea cycle disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 46 publications
0
10
0
Order By: Relevance
“…Most notably, the expression of proteins involved in nitrogen processing is induced, causing an increase in ammonia and urea levels in the liver and blood [ 40 , 43 ]. In several different studies, aberrations in the urea cycle were connected with higher rates of liver inflammation, increased liver disease burden, and liver pathologies [ 44 , 45 , 46 , 47 ]. This mechanism could explain the observed increase in inflammation upon the start of a high-protein diet via the activation of innate immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…Most notably, the expression of proteins involved in nitrogen processing is induced, causing an increase in ammonia and urea levels in the liver and blood [ 40 , 43 ]. In several different studies, aberrations in the urea cycle were connected with higher rates of liver inflammation, increased liver disease burden, and liver pathologies [ 44 , 45 , 46 , 47 ]. This mechanism could explain the observed increase in inflammation upon the start of a high-protein diet via the activation of innate immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…The liver pathology persists and can worsen despite appropriate ammonia control under standard of care, suggesting hyperammonaemia is not the sole cause (7). Accumulation of toxic metabolites such as argininosuccinic acid, potentially facilitated by high arginine supplementation could be contributing factors (6, 9, 34).…”
Section: Discussionmentioning
confidence: 99%
“…Early-onset patients display hyperammonemia, while late-onset patients present with either acute hyperammonaemia and/or chronic phenotype of neurocognitive impairment and liver disease (3). Compared to other UCDs, ASA is associated with a high burden of chronic liver complications such as elevated levels of serum transaminases, hepatomegaly, fibrosis, steatosis, hepatocellular injury and glycogen storage both in patients (6)(7)(8)(9)(10) and in the mouse model Asl Neo/Neo (8,11). Some patients present with liver cirrhosis or, rarely, hepatocellular carcinoma (9,12,13).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chronic liver dysfunction causes morbidity in all UCD subtypes (13,14) but is reported with higher frequency and severity in ASA (1,11,13,15). This liver disease commonly manifests with hepatomegaly and transaminitis and can progress to liver failure and, eventually, hepatocellular carcinoma (11,(14)(15)(16)(17)(18)(19). Liver pathology progresses despite appropriate ammonia control, suggesting that hyperammonemia is not the sole cause (14).…”
Section: Introductionmentioning
confidence: 99%